In the present work, we showed that both plasma Abeta(1-42/1-40) and plasma GFAP are independently associated with amyloid pathology as measured by PET in a cohort of individuals with SCD, MCI, and AD-dementia. Here, GFAP is linked to Alzheimer disease.